Cargando…
Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537026/ https://www.ncbi.nlm.nih.gov/pubmed/25922914 |
_version_ | 1782385834864934912 |
---|---|
author | Harman, María F. Ranocchia, Romina P. Gorlino, Carolina V. Sánchez Vallecillo, María F. Castell, Sofía D. Crespo, María I. Maletto, Belkys A. Morón, Gabriel Pistoresi-Palencia, María C. |
author_facet | Harman, María F. Ranocchia, Romina P. Gorlino, Carolina V. Sánchez Vallecillo, María F. Castell, Sofía D. Crespo, María I. Maletto, Belkys A. Morón, Gabriel Pistoresi-Palencia, María C. |
author_sort | Harman, María F. |
collection | PubMed |
description | As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG-ODN) emulsified in incomplete Freund's adjuvant (IFA), (CpG-ODN+IFA) an inflammatory stimulus, led to the expansion of CD11b(+)Gr1(+) myeloid cells with augmented expression of CD124 and CD31. These myeloid cells lasted longer in the spleen of aged mice than in their younger counterparts after CpG-ODN+IFA treatment and were capable of suppressing T cell proliferative response by arginase induction. Myeloid cells from aged CpG-ODN+IFA-treated mice presented increased arginase-1 expression and enzyme activity. In addition, we found a different requirement of cytokines for arginase induction according to mice age. In myeloid cells from young treated mice, arginase-1 expression and activity is induced by the presence of each IL-4 or IL-6 in their extracellular medium, unlike myeloid cells from aged treated mice which need the presence of both IL-4 and IL-6 together for arginase induction and suppressor function. |
format | Online Article Text |
id | pubmed-4537026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-45370262015-08-26 Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment Harman, María F. Ranocchia, Romina P. Gorlino, Carolina V. Sánchez Vallecillo, María F. Castell, Sofía D. Crespo, María I. Maletto, Belkys A. Morón, Gabriel Pistoresi-Palencia, María C. Oncotarget Research Paper As we age, the homeostatic function of many systems in the body, such as the immune function declines, which in turn contributes to augment susceptibility to disease. Here we describe that challenging aged mice with synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG-ODN) emulsified in incomplete Freund's adjuvant (IFA), (CpG-ODN+IFA) an inflammatory stimulus, led to the expansion of CD11b(+)Gr1(+) myeloid cells with augmented expression of CD124 and CD31. These myeloid cells lasted longer in the spleen of aged mice than in their younger counterparts after CpG-ODN+IFA treatment and were capable of suppressing T cell proliferative response by arginase induction. Myeloid cells from aged CpG-ODN+IFA-treated mice presented increased arginase-1 expression and enzyme activity. In addition, we found a different requirement of cytokines for arginase induction according to mice age. In myeloid cells from young treated mice, arginase-1 expression and activity is induced by the presence of each IL-4 or IL-6 in their extracellular medium, unlike myeloid cells from aged treated mice which need the presence of both IL-4 and IL-6 together for arginase induction and suppressor function. Impact Journals LLC 2015-04-13 /pmc/articles/PMC4537026/ /pubmed/25922914 Text en Copyright: © 2015 Harman et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Harman, María F. Ranocchia, Romina P. Gorlino, Carolina V. Sánchez Vallecillo, María F. Castell, Sofía D. Crespo, María I. Maletto, Belkys A. Morón, Gabriel Pistoresi-Palencia, María C. Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title_full | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title_fullStr | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title_full_unstemmed | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title_short | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
title_sort | expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after cpg-odn plus ifa treatment |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537026/ https://www.ncbi.nlm.nih.gov/pubmed/25922914 |
work_keys_str_mv | AT harmanmariaf expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT ranocchiarominap expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT gorlinocarolinav expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT sanchezvallecillomariaf expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT castellsofiad expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT crespomariai expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT malettobelkysa expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT morongabriel expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment AT pistoresipalenciamariac expansionofmyeloidderivedsuppressorcellswitharginaseactivitylastslongerinagedthaninyoungmiceaftercpgodnplusifatreatment |